The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global General Influenza Diagnostics Market Research Report 2025
Synopsis
Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.
The global General Influenza Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Influenza Diagnostics.
Report Scope
The General Influenza Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Segment by Type
RIDT
Viral Culture
DFA
Serological Assays
Segment by Application
Hospitals
Clinical Laboratories
Other End-User
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Influenza Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Influenza virus testing is not required to make a clinical diagnosis of Influenza in outpatients with suspected Influenza,Particularly during increased state-run activity when seasonal state-run influenza A and B viruses are circulating in the local community. The traditional detection methods include: RIDT, Viral Culture, DFA, Serological assays.
The global General Influenza Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for General Influenza Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding General Influenza Diagnostics.
Report Scope
The General Influenza Diagnostics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global General Influenza Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the General Influenza Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Segment by Type
RIDT
Viral Culture
DFA
Serological Assays
Segment by Application
Hospitals
Clinical Laboratories
Other End-User
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of General Influenza Diagnostics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global General Influenza Diagnostics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 RIDT
1.2.3 Viral Culture
1.2.4 DFA
1.2.5 Serological Assays
1.3 Market by Application
1.3.1 Global General Influenza Diagnostics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinical Laboratories
1.3.4 Other End-User
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global General Influenza Diagnostics Market Perspective (2019-2030)
2.2 General Influenza Diagnostics Growth Trends by Region
2.2.1 Global General Influenza Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 General Influenza Diagnostics Historic Market Size by Region (2019-2024)
2.2.3 General Influenza Diagnostics Forecasted Market Size by Region (2025-2030)
2.3 General Influenza Diagnostics Market Dynamics
2.3.1 General Influenza Diagnostics Industry Trends
2.3.2 General Influenza Diagnostics Market Drivers
2.3.3 General Influenza Diagnostics Market Challenges
2.3.4 General Influenza Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top General Influenza Diagnostics Players by Revenue
3.1.1 Global Top General Influenza Diagnostics Players by Revenue (2019-2024)
3.1.2 Global General Influenza Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global General Influenza Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by General Influenza Diagnostics Revenue
3.4 Global General Influenza Diagnostics Market Concentration Ratio
3.4.1 Global General Influenza Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by General Influenza Diagnostics Revenue in 2023
3.5 General Influenza Diagnostics Key Players Head office and Area Served
3.6 Key Players General Influenza Diagnostics Product Solution and Service
3.7 Date of Enter into General Influenza Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 General Influenza Diagnostics Breakdown Data by Type
4.1 Global General Influenza Diagnostics Historic Market Size by Type (2019-2024)
4.2 Global General Influenza Diagnostics Forecasted Market Size by Type (2025-2030)
5 General Influenza Diagnostics Breakdown Data by Application
5.1 Global General Influenza Diagnostics Historic Market Size by Application (2019-2024)
5.2 Global General Influenza Diagnostics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America General Influenza Diagnostics Market Size (2019-2030)
6.2 North America General Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America General Influenza Diagnostics Market Size by Country (2019-2024)
6.4 North America General Influenza Diagnostics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe General Influenza Diagnostics Market Size (2019-2030)
7.2 Europe General Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe General Influenza Diagnostics Market Size by Country (2019-2024)
7.4 Europe General Influenza Diagnostics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific General Influenza Diagnostics Market Size (2019-2030)
8.2 Asia-Pacific General Influenza Diagnostics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific General Influenza Diagnostics Market Size by Region (2019-2024)
8.4 Asia-Pacific General Influenza Diagnostics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America General Influenza Diagnostics Market Size (2019-2030)
9.2 Latin America General Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America General Influenza Diagnostics Market Size by Country (2019-2024)
9.4 Latin America General Influenza Diagnostics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa General Influenza Diagnostics Market Size (2019-2030)
10.2 Middle East & Africa General Influenza Diagnostics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa General Influenza Diagnostics Market Size by Country (2019-2024)
10.4 Middle East & Africa General Influenza Diagnostics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Detail
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche General Influenza Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2019-2024)
11.1.5 F. Hoffmann-La Roche Recent Development
11.2 Quidel Corporation
11.2.1 Quidel Corporation Company Detail
11.2.2 Quidel Corporation Business Overview
11.2.3 Quidel Corporation General Influenza Diagnostics Introduction
11.2.4 Quidel Corporation Revenue in General Influenza Diagnostics Business (2019-2024)
11.2.5 Quidel Corporation Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific General Influenza Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2019-2024)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Detail
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories General Influenza Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in General Influenza Diagnostics Business (2019-2024)
11.4.5 Abbott Laboratories Recent Development
11.5 Becton, Dickinson, and Company
11.5.1 Becton, Dickinson, and Company Company Detail
11.5.2 Becton, Dickinson, and Company Business Overview
11.5.3 Becton, Dickinson, and Company General Influenza Diagnostics Introduction
11.5.4 Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2019-2024)
11.5.5 Becton, Dickinson, and Company Recent Development
11.6 DiaSorin
11.6.1 DiaSorin Company Detail
11.6.2 DiaSorin Business Overview
11.6.3 DiaSorin General Influenza Diagnostics Introduction
11.6.4 DiaSorin Revenue in General Influenza Diagnostics Business (2019-2024)
11.6.5 DiaSorin Recent Development
11.7 bioMérieux
11.7.1 bioMérieux Company Detail
11.7.2 bioMérieux Business Overview
11.7.3 bioMérieux General Influenza Diagnostics Introduction
11.7.4 bioMérieux Revenue in General Influenza Diagnostics Business (2019-2024)
11.7.5 bioMérieux Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global General Influenza Diagnostics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of RIDT
Table 3. Key Players of Viral Culture
Table 4. Key Players of DFA
Table 5. Key Players of Serological Assays
Table 6. Global General Influenza Diagnostics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global General Influenza Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global General Influenza Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global General Influenza Diagnostics Market Share by Region (2019-2024)
Table 10. Global General Influenza Diagnostics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global General Influenza Diagnostics Market Share by Region (2025-2030)
Table 12. General Influenza Diagnostics Market Trends
Table 13. General Influenza Diagnostics Market Drivers
Table 14. General Influenza Diagnostics Market Challenges
Table 15. General Influenza Diagnostics Market Restraints
Table 16. Global General Influenza Diagnostics Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global General Influenza Diagnostics Market Share by Players (2019-2024)
Table 18. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Influenza Diagnostics as of 2023)
Table 19. Ranking of Global Top General Influenza Diagnostics Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by General Influenza Diagnostics Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players General Influenza Diagnostics Product Solution and Service
Table 23. Date of Enter into General Influenza Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global General Influenza Diagnostics Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global General Influenza Diagnostics Revenue Market Share by Type (2019-2024)
Table 27. Global General Influenza Diagnostics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global General Influenza Diagnostics Revenue Market Share by Type (2025-2030)
Table 29. Global General Influenza Diagnostics Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global General Influenza Diagnostics Revenue Market Share by Application (2019-2024)
Table 31. Global General Influenza Diagnostics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global General Influenza Diagnostics Revenue Market Share by Application (2025-2030)
Table 33. North America General Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America General Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America General Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe General Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe General Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe General Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific General Influenza Diagnostics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific General Influenza Diagnostics Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific General Influenza Diagnostics Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America General Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America General Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America General Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa General Influenza Diagnostics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa General Influenza Diagnostics Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa General Influenza Diagnostics Market Size by Country (2025-2030) & (US$ Million)
Table 48. F. Hoffmann-La Roche Company Detail
Table 49. F. Hoffmann-La Roche Business Overview
Table 50. F. Hoffmann-La Roche General Influenza Diagnostics Product
Table 51. F. Hoffmann-La Roche Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 52. F. Hoffmann-La Roche Recent Development
Table 53. Quidel Corporation Company Detail
Table 54. Quidel Corporation Business Overview
Table 55. Quidel Corporation General Influenza Diagnostics Product
Table 56. Quidel Corporation Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 57. Quidel Corporation Recent Development
Table 58. Thermo Fisher Scientific Company Detail
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific General Influenza Diagnostics Product
Table 61. Thermo Fisher Scientific Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Abbott Laboratories Company Detail
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories General Influenza Diagnostics Product
Table 66. Abbott Laboratories Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. Becton, Dickinson, and Company Company Detail
Table 69. Becton, Dickinson, and Company Business Overview
Table 70. Becton, Dickinson, and Company General Influenza Diagnostics Product
Table 71. Becton, Dickinson, and Company Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 72. Becton, Dickinson, and Company Recent Development
Table 73. DiaSorin Company Detail
Table 74. DiaSorin Business Overview
Table 75. DiaSorin General Influenza Diagnostics Product
Table 76. DiaSorin Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 77. DiaSorin Recent Development
Table 78. bioMérieux Company Detail
Table 79. bioMérieux Business Overview
Table 80. bioMérieux General Influenza Diagnostics Product
Table 81. bioMérieux Revenue in General Influenza Diagnostics Business (2019-2024) & (US$ Million)
Table 82. bioMérieux Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global General Influenza Diagnostics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global General Influenza Diagnostics Market Share by Type: 2023 VS 2030
Figure 3. RIDT Features
Figure 4. Viral Culture Features
Figure 5. DFA Features
Figure 6. Serological Assays Features
Figure 7. Global General Influenza Diagnostics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global General Influenza Diagnostics Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinical Laboratories Case Studies
Figure 11. Other End-User Case Studies
Figure 12. General Influenza Diagnostics Report Years Considered
Figure 13. Global General Influenza Diagnostics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global General Influenza Diagnostics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global General Influenza Diagnostics Market Share by Region: 2023 VS 2030
Figure 16. Global General Influenza Diagnostics Market Share by Players in 2023
Figure 17. Global Top General Influenza Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in General Influenza Diagnostics as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by General Influenza Diagnostics Revenue in 2023
Figure 19. North America General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America General Influenza Diagnostics Market Share by Country (2019-2030)
Figure 21. United States General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe General Influenza Diagnostics Market Share by Country (2019-2030)
Figure 25. Germany General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific General Influenza Diagnostics Market Share by Region (2019-2030)
Figure 33. China General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America General Influenza Diagnostics Market Share by Country (2019-2030)
Figure 41. Mexico General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa General Influenza Diagnostics Market Share by Country (2019-2030)
Figure 45. Turkey General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia General Influenza Diagnostics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. F. Hoffmann-La Roche Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 48. Quidel Corporation Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 50. Abbott Laboratories Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 51. Becton, Dickinson, and Company Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 52. DiaSorin Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 53. bioMérieux Revenue Growth Rate in General Influenza Diagnostics Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
